Veronica R. Placencio

841 total citations
13 papers, 666 citations indexed

About

Veronica R. Placencio is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Veronica R. Placencio has authored 13 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Veronica R. Placencio's work include Protease and Inhibitor Mechanisms (5 papers), Prostate Cancer Treatment and Research (4 papers) and Cell Adhesion Molecules Research (4 papers). Veronica R. Placencio is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Prostate Cancer Treatment and Research (4 papers) and Cell Adhesion Molecules Research (4 papers). Veronica R. Placencio collaborates with scholars based in United States and Japan. Veronica R. Placencio's co-authors include Yves A. DeClerck, Neil A. Bhowmick, Ali‐Reza Sharif‐Afshar, Simon W. Hayward, Consolate Uwamariya, Fang Hua, Xiaohong Li, Tatsuki Koyama, Juan M. Iturregui and Toshio Miyata and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Veronica R. Placencio

13 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veronica R. Placencio United States 8 354 238 230 212 91 13 666
Paulisally Hau Yi Lo United States 18 448 1.3× 242 1.0× 178 0.8× 92 0.4× 69 0.8× 20 695
Ana Teresa Amaral Spain 13 317 0.9× 150 0.6× 206 0.9× 244 1.2× 62 0.7× 20 633
Christine To Canada 9 391 1.1× 196 0.8× 323 1.4× 173 0.8× 60 0.7× 11 708
Harald Hugenschmidt Norway 11 384 1.1× 267 1.1× 417 1.8× 189 0.9× 107 1.2× 13 826
Yvonne Parker United States 13 378 1.1× 223 0.9× 194 0.8× 142 0.7× 105 1.2× 24 734
Carlo Fusco Switzerland 7 224 0.6× 193 0.8× 213 0.9× 101 0.5× 71 0.8× 8 520
Loredana Militello Italy 9 355 1.0× 205 0.9× 319 1.4× 197 0.9× 106 1.2× 19 746
Nadia Coltella Italy 16 387 1.1× 206 0.9× 194 0.8× 114 0.5× 109 1.2× 24 709
Anna-Maria Larsson Sweden 14 232 0.7× 345 1.4× 480 2.1× 135 0.6× 226 2.5× 27 859
Cristina Pons Spain 17 478 1.4× 303 1.3× 299 1.3× 109 0.5× 107 1.2× 24 1.2k

Countries citing papers authored by Veronica R. Placencio

Since Specialization
Citations

This map shows the geographic impact of Veronica R. Placencio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica R. Placencio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica R. Placencio more than expected).

Fields of papers citing papers by Veronica R. Placencio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica R. Placencio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica R. Placencio. The network helps show where Veronica R. Placencio may publish in the future.

Co-authorship network of co-authors of Veronica R. Placencio

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica R. Placencio. A scholar is included among the top collaborators of Veronica R. Placencio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica R. Placencio. Veronica R. Placencio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hendifar, Andrew, Brent K. Larson, Michelle Guan, et al.. (2019). Pancreatic cancer ‘mismatch’ in Lynch syndrome. BMJ Open Gastroenterology. 6(1). e000274–e000274. 7 indexed citations
2.
Larson, Brent K., Michelle Guan, Veronica R. Placencio, Richard Tuli, & Andrew Hendifar. (2019). Stromal hyaluronan accumulation is associated with low tumor grade and nodal metastases in pancreatic ductal adenocarcinoma. Human Pathology. 90. 37–44. 7 indexed citations
3.
Tuli, Richard, Nicholas N. Nissen, Simon S. Lo, et al.. (2019). Abstract B58: A phase I/II study of durvalumab and stereotactic radiotherapy in locally advanced pancreatic cancer. Cancer Research. 79(24_Supplement). B58–B58. 5 indexed citations
4.
Mishra, Rajeev, Subhash Haldar, Veronica R. Placencio, et al.. (2018). Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming. Journal of Clinical Investigation. 128(10). 4472–4484. 124 indexed citations
5.
Kubala, Marta H., Veronica R. Placencio, & Yves A. DeClerck. (2017). Abstract 3061: Tumor-derived PAI-1 promotes macrophage M2 polarization by stimulating an autocrine IL-6 /STAT3 pathway. Cancer Research. 77(13_Supplement). 3061–3061. 2 indexed citations
6.
Kubala, Marta H., Veronica R. Placencio, & Yves A. DeClerck. (2015). Plasminogen activator inhibitor-1 increases migration of monocytes to the tumor and skews their differentiation towards M2 macrophage phenotype (TUM6P.1002). The Journal of Immunology. 194(1_Supplement). 141.26–141.26. 2 indexed citations
7.
Placencio, Veronica R., Atsuhiko Ichimura, Toshio Miyata, & Yves A. DeClerck. (2015). Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity. PLoS ONE. 10(7). e0133786–e0133786. 40 indexed citations
8.
Placencio, Veronica R. & Yves A. DeClerck. (2015). Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing. Cancer Research. 75(15). 2969–2974. 145 indexed citations
9.
Placencio, Veronica R., Toshio Miyata, & Yves A. DeClerck. (2013). Abstract 1548: Pharmacologic inhibition of PAI-1 increases apoptosis and inhibits macrophage migration in cancer.. Cancer Research. 73(8_Supplement). 1548–1548. 2 indexed citations
10.
Hua, Fang, Veronica R. Placencio, & Yves A. DeClerck. (2012). Protumorigenic Activity of Plasminogen Activator Inhibitor-1 Through an Antiapoptotic Function. JNCI Journal of the National Cancer Institute. 104(19). 1470–1484. 73 indexed citations
11.
Placencio, Veronica R., et al.. (2010). Bone Marrow Derived Mesenchymal Stem Cells Incorporate into the Prostate during Regrowth. PLoS ONE. 5(9). e12920–e12920. 44 indexed citations
12.
Placencio, Veronica R., Ali‐Reza Sharif‐Afshar, Xiaohong Li, et al.. (2008). Stromal Transforming Growth Factor-β Signaling Mediates Prostatic Response to Androgen Ablation by Paracrine Wnt Activity. Cancer Research. 68(12). 4709–4718. 90 indexed citations
13.
Placencio, Veronica R., Juan M. Iturregui, Consolate Uwamariya, et al.. (2008). Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis. Oncogene. 27(56). 7118–7130. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026